Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 451 AL 465

Perspective on the "2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease"

Khachaturian ZS.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S265-8. doi: 10.1016/j.jalz.2014.08.102.

Stem cell treatment for Alzheimer's disease

Li M, Guo K, Ikehara S.

Int J Mol Sci. 2014 Oct 23;15(10):19226-38. doi: 10.3390/ijms151019226.

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

Mushtaq G, Greig NH, Khan JA, Kamal MA.

CNS Neurol Disord Drug Targets. 2014;13(8):1432-9. doi: 10.2174/1871527313666141023141545.

Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease

Ahmad MZ, Ahmad J, Amin S, Rahman M, Anwar M, Mallick N, Ahmad FJ, Rahman Z, Kamal MA, Akhter S.

CNS Neurol Disord Drug Targets. 2014;13(8):1315-24. doi: 10.2174/1871527313666141023100618.

Retinal microvasculature in Alzheimer's disease

Cheung CY, Ong YT, Ikram MK, Chen C, Wong TY.

J Alzheimers Dis. 2014;42 Suppl 4:S339-52. doi: 10.3233/JAD-141596.

[Economic impact of Alzheimer's Disease in Brazil: is it possible to improve care and minimize costs?]

Gutierrez BA, Silva HS, Guimarães C, Campino AC.

Cien Saude Colet. 2014 Nov;19(11):4479-86. doi: 10.1590/1413-812320141911.03562013.

Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms

Kim J, Yoon H, Basak J, Kim J.

Mol Cells. 2014 Nov;37(11):767-76. doi: 10.14348/molcells.2014.0248. Epub 2014 Oct 30.

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease

Paroni G, Seripa D, Fontana A, D'Onofrio G, Gravina C, Urbano M, Cascavilla L, Pellegrini F, Greco A, Pilotto A.

Clin Interv Aging. 2014 Oct 21;9:1783-91. doi: 10.2147/CIA.S64758. eCollection 2014.

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?

Millan MJ.

Dialogues Clin Neurosci. 2014 Sep;16(3):373-93. doi: 10.31887/DCNS.2014.16.3/mmillan.

Éditorial

Derouesné C.

Geriatr Psychol Neuropsychiatr Vieil. 2014 Sep;12(3):285-7.

Heat shock protein 90 in Alzheimer's disease

Ou JR, Tan MS, Xie AM, Yu JT, Tan L.

Biomed Res Int. 2014;2014:796869. doi: 10.1155/2014/796869. Epub 2014 Oct 13.

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue

Lesne SE.

Swiss Med Wkly. 2014 Nov 6;144:w14021. doi: 10.4414/smw.2014.14021. eCollection 2014.

The overlap between vascular disease and Alzheimer's disease--lessons from pathology

Attems J, Jellinger KA.

BMC Med. 2014 Nov 11;12:206. doi: 10.1186/s12916-014-0206-2.

Structure and mechanism of action of tau aggregation inhibitors

Cisek K, Cooper GL, Huseby CJ, Kuret J.

Curr Alzheimer Res. 2014;11(10):918-27. doi: 10.2174/1567205011666141107150331.

Locus (coeruleus) minoris resistentiae in pathogenesis of Alzheimer's disease

Mravec B, Lejavova K, Cubinkova V.

Curr Alzheimer Res. 2014;11(10):992-1001. doi: 10.2174/1567205011666141107130505.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias